16 citations
,
May 2019 in “International Journal of Women's Dermatology”
The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.
Oral minoxidil is discussed, highlighting potential cardiovascular risks at high doses, but users note that lower doses commonly used for hair loss are generally considered safe. Monitoring by doctors is advised, and some users report taking it without issues, comparing its risks to those of common medications like ibuprofen.
Hair cloning and injection of dermal papilla cells are discussed, with skepticism about their availability by 2023. Users mention Minoxidil, finasteride, and hair transplants as current treatments.
Evidence-based treatments for androgenic alopecia, such as minoxidil, finasteride, low-level laser light therapy, dutasteride, platelet-rich plasma, and topical ketoconazole. It discusses the efficacy, safety, and mechanism of action of these treatments, as well as future developments in understanding this polygenic condition.
Regrowing hair with finasteride and minoxidil can boost confidence and improve dating prospects. However, confidence and personality are considered more important than appearance in relationships.
The post warns about fake Kirkland minoxidil being sold on eBay in Australia, confirmed by lab tests showing no minoxidil content. Users discuss their experiences, suggest a bleach test for authenticity, and highlight the importance of buying from reputable suppliers.